MCVAX
Price
$11.69
Change
-$0.09 (-0.76%)
Updated
Sep 20 closing price
VMVAX
Price
$86.17
Change
-$0.37 (-0.43%)
Updated
Sep 20 closing price
Ad is loading...

MCVAX vs VMVAX

Header iconMCVAX vs VMVAX Comparison
Open Charts MCVAX vs VMVAXBanner chart's image
Transamerica Mid Cap Value Opps A
Price$11.69
Change-$0.09 (-0.76%)
VolumeN/A
CapitalizationN/A
Vanguard Mid-Cap Value Index Admiral
Price$86.17
Change-$0.37 (-0.43%)
VolumeN/A
CapitalizationN/A
View a ticker or compare two or three
MCVAX vs VMVAX Comparison Chart
Loading...
VS
MCVAX vs. VMVAX commentary
Sep 21, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MCVAX is a Buy and VMVAX is a StrongBuy.

FUNDAMENTALS
Fundamentals
VMVAX has more cash in the bank: 30.5B vs. MCVAX (1.25B). VMVAX pays higher dividends than MCVAX: VMVAX (2.14) vs MCVAX (0.52). MCVAX was incepted earlier than VMVAX: MCVAX (10 years) vs VMVAX (13 years). MCVAX is a more actively managed with annual turnover of: 44.00 vs. VMVAX (22.00). MCVAX has a lower initial minimum investment than VMVAX: MCVAX (1000) vs VMVAX (3000). VMVAX annual gain was more profitable for investors over the last year : 25.35 vs. MCVAX (9.98). VMVAX return over 5 years is better than : 48.82 vs. MCVAX (1.38).
MCVAXVMVAXMCVAX / VMVAX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence10 years13 years-
Gain YTD7.74214.94652%
Front LoadN/AN/A-
Min. Initial Investment1000300033%
Min. Initial Investment IRAN/AN/A-
Net Assets1.25B30.5B4%
Annual Yield % from dividends0.522.1425%
Returns for 1 year9.9825.3539%
Returns for 3 years-16.2020.71-78%
Returns for 5 years1.3848.823%
Returns for 10 years16.22100.8816%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
AUUD0.790.01
+0.67%
Auddia
CTLT60.00-0.11
-0.18%
CATALENT
JAMF18.49-0.09
-0.48%
Jamf Holding Corp
ARCT20.61-0.41
-1.95%
Arcturus Therapeutics Holdings
ANVS8.47-0.17
-1.97%
Annovis Bio